Duration of prophylaxis with trimethoprim-sulfamethoxazole in patients undergoing solid organ transplantation

被引：6
|
作者：
Malhotra, P. [1 ]
Rai, S. D. [1 ]
Hirschwerk, D. [1 ]
机构：
[1] Hofstra N Shore LIJ Sch Med, Div Infect Dis, Dept Med, Manhasset, NY 11030 USA
来源：
INFECTION | 2012年 / 40卷 / 04期
关键词：
PNEUMOCYSTIS-JIROVECI PNEUMONIA; RENAL-TRANSPLANTATION; RISK-FACTORS; RECIPIENTS; INFECTION; GLOBULIN; PREVENTION; REJECTION; INDUCTION; CARINII;
D O I：
10.1007/s15010-012-0277-y
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：473 / 475
页数：3
相关论文
共 50 条
  • [21] A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND-STUDY OF TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PROPHYLAXIS OF INFECTION IN RENAL-TRANSPLANTATION - SIDE-EFFECTS OF TRIMETHOPRIM-SULFAMETHOXAZOLE, INTERACTION WITH CYCLOSPORINE
    MAKI, DG
    FOX, BC
    KUNTZ, J
    SOLLINGER, HW
    BELZER, FO
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1992, 119 (01): : 11 - 24
  • [22] TRIMETHOPRIM-SULFAMETHOXAZOLE PHARMACOKINETICS IN TRAUMA PATIENTS
    HESS, MM
    BOUCHER, BA
    LAIZURE, SC
    STEVENS, RC
    SANDERS, PL
    JANNING, SW
    CROCE, MA
    FABIAN, TC
    PHARMACOTHERAPY, 1993, 13 (06): : 602 - 606
  • [23] MYELOSUPPRESSION EFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS IN PRIMARY IMMUNE DEFICIENCY DISEASE PATIENTS
    Adeli, Mehdi
    Elajez, Reem
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (02) : 234 - 234
  • [24] LOW-DOSE TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS
    CARR, A
    TINDALL, B
    BREW, BJ
    MARRIOTT, DJ
    HARKNESS, JL
    PENNY, R
    COOPER, DA
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) : 106 - 111
  • [25] Reinstituting trimethoprim-sulfamethoxazole in patients receiving atovapuone for Pneumocystis carinii pneumonia prophylaxis
    James, CW
    McNelis, KC
    Szabo, S
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (15) : 1572 - 1574
  • [26] A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND-STUDY OF TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PROPHYLAXIS OF INFECTION IN RENAL-TRANSPLANTATION - CLINICAL EFFICACY, ABSORPTION OF TRIMETHOPRIM-SULFAMETHOXAZOLE, EFFECTS ON THE MICROFLORA, AND THE COST-BENEFIT OF PROPHYLAXIS
    FOX, BC
    SOLLINGER, HW
    BELZER, FO
    MAKI, DG
    AMERICAN JOURNAL OF MEDICINE, 1990, 89 (03): : 255 - 274
  • [27] TRIMETHOPRIM-SULFAMETHOXAZOLE AND TRIMETHOPRIM ALONE IN THE PROPHYLAXIS OF CHILDHOOD URINARY-TRACT INFECTION
    SMELLIE, JM
    GRUNEBERG, RN
    NORMAND, ICS
    BANTOCK, HM
    REVIEWS OF INFECTIOUS DISEASES, 1982, 4 (02): : 461 - 466
  • [28] TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN INFANTS
    MUELLER, BU
    PIZZO, PA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (12) : 1072 - 1073
  • [29] Septicemia due to susceptibleEnterococcus faecalis despite prophylaxis with trimethoprim-sulfamethoxazole
    H. -A. Elsner
    W. Krüger
    R. Laufs
    D. Mack
    European Journal of Clinical Microbiology and Infectious Diseases, 1997, 16 : 620 - 622
  • [30] Adverse effects of trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis pneumonia in dermatology
    Kokubu, Hiraku
    Kato, Takeshi
    Nishikawa, Junko
    Tanaka, Toshihiro
    Fujimoto, Noriki
    JOURNAL OF DERMATOLOGY, 2021, 48 (04): : 542 - 546
12345